These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 3014349)
1. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Quintanilla M; Brown K; Ramsden M; Balmain A Nature; 1986 Jul 3-9; 322(6074):78-80. PubMed ID: 3014349 [TBL] [Abstract][Full Text] [Related]
2. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
3. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells. Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957 [TBL] [Abstract][Full Text] [Related]
4. Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours. Yamasaki H; Hollstein M; Cabral JR; Tomatis L IARC Sci Publ; 1989; (96):221-37. PubMed ID: 2680947 [TBL] [Abstract][Full Text] [Related]
5. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
6. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein. Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294 [TBL] [Abstract][Full Text] [Related]
7. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
8. [Activation of oncogenes by chemical modification with carcinogens]. Hashimoto Y; Shudo K Gan To Kagaku Ryoho; 1986 Dec; 13(12):3354-64. PubMed ID: 3098180 [TBL] [Abstract][Full Text] [Related]
9. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras. Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761 [TBL] [Abstract][Full Text] [Related]
10. Initiation of skin carcinogenesis can occur by induction of carcinogen-specific point mutations in the Harvey-ras gene. Bailleul B; Brown K; Ramsden M; Fee F; Balmain A Prog Clin Biol Res; 1989; 298():137-45. PubMed ID: 2664807 [No Abstract] [Full Text] [Related]
11. [Presence of specific mutation of Ha-ras oncogene in skin tumors of mice induced under different experimental conditions]. Loktionov AS; Popovich IG; Zabezhinskiĭ MA; Anisimov VN Biull Eksp Biol Med; 1991 Apr; 111(4):398-400. PubMed ID: 1909909 [TBL] [Abstract][Full Text] [Related]
12. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717 [TBL] [Abstract][Full Text] [Related]
13. Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. Nakazawa H; Aguelon AM; Yamasaki H Oncogene; 1992 Nov; 7(11):2295-301. PubMed ID: 1437151 [TBL] [Abstract][Full Text] [Related]
14. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021 [TBL] [Abstract][Full Text] [Related]
15. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin. Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ Mol Carcinog; 1999 Nov; 26(3):150-6. PubMed ID: 10559789 [TBL] [Abstract][Full Text] [Related]
17. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Roop DR; Lowy DR; Tambourin PE; Strickland J; Harper JR; Balaschak M; Spangler EF; Yuspa SH Nature; 1986 Oct 30-Nov 5; 323(6091):822-4. PubMed ID: 2430189 [TBL] [Abstract][Full Text] [Related]
18. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236 [TBL] [Abstract][Full Text] [Related]
19. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Brown K; Buchmann A; Balmain A Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486 [TBL] [Abstract][Full Text] [Related]
20. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]